Beijing Tiantan Biological Products Statistics

Total Valuation

Beijing Tiantan Biological Products has a market cap or net worth of CNY 43.56 billion. The enterprise value is 42.00 billion.

Market Cap	43.56B
Enterprise Value	42.00B

Important Dates

The last earnings date was Friday, October 25, 2024.

Earnings Date	Oct 25, 2024
Ex-Dividend Date	Jun 20, 2024

Share Statistics

Beijing Tiantan Biological Products has 1.98 billion shares outstanding. The number of shares has increased by 1.32% in one year.

Current Share Class	n/a
Shares Outstanding	1.98B
Shares Change (YoY)	+1.32%
Shares Change (QoQ)	+2.26%
Owned by Insiders (%)	2.80%
Owned by Institutions (%)	15.42%
Float	949.60M

Valuation Ratios

The trailing PE ratio is 34.53 and the forward PE ratio is 31.68.

PE Ratio	34.53
Forward PE	31.68
PS Ratio	8.41
PB Ratio	4.09
P/TBV Ratio	n/a
P/FCF Ratio	161.44
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.09, with an EV/FCF ratio of 155.67.

EV / Earnings	32.96
EV / Sales	8.03
EV / EBITDA	18.09
EV / EBIT	21.10
EV / FCF	155.67

Financial Position

The company has a current ratio of 5.51, with a Debt / Equity ratio of 0.00.

Current Ratio	5.51
Quick Ratio	3.28
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.15
Interest Coverage	582.11

Financial Efficiency

Return on equity (ROE) is 13.14% and return on invested capital (ROIC) is 9.36%.

Return on Equity (ROE)	13.14%
Return on Assets (ROA)	8.25%
Return on Capital (ROIC)	9.36%
Revenue Per Employee	1.08M
Profits Per Employee	262,291
Employee Count	4,858
Asset Turnover	0.35
Inventory Turnover	0.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.66% in the last 52 weeks. The beta is 0.31, so Beijing Tiantan Biological Products's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-12.66%
50-Day Moving Average	22.40
200-Day Moving Average	23.47
Relative Strength Index (RSI)	47.75
Average Volume (20 Days)	20,836,973

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Beijing Tiantan Biological Products had revenue of CNY 5.23 billion and earned 1.27 billion in profits. Earnings per share was 0.64.

Revenue	5.23B
Gross Profit	2.89B
Operating Income	1.99B
Pretax Income	2.08B
Net Income	1.27B
EBITDA	2.30B
EBIT	1.99B
Earnings Per Share (EPS)	0.64

Full Income Statement

Balance Sheet

The company has 4.80 billion in cash and 39.25 million in debt, giving a net cash position of 4.77 billion or 2.41 per share.

Cash & Cash Equivalents	4.80B
Total Debt	39.25M
Net Cash	4.77B
Net Cash Per Share	2.41
Equity (Book Value)	13.85B
Book Value Per Share	5.38
Working Capital	6.99B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.35 billion and capital expenditures -1.08 billion, giving a free cash flow of 269.83 million.

Operating Cash Flow	1.35B
Capital Expenditures	-1.08B
Free Cash Flow	269.83M
FCF Per Share	0.14

Full Cash Flow Statement

Margins

Gross margin is 55.17%, with operating and profit margins of 38.06% and 24.36%.

Gross Margin	55.17%
Operating Margin	38.06%
Pretax Margin	39.79%
Profit Margin	24.36%
EBITDA Margin	43.99%
EBIT Margin	38.06%
FCF Margin	5.16%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.57%.

Dividend Per Share	0.13
Dividend Yield	0.57%
Dividend Growth (YoY)	259.97%
Years of Dividend Growth	n/a
Payout Ratio	19.50%
Buyback Yield	-1.32%
Shareholder Yield	-0.75%
Earnings Yield	2.90%
FCF Yield	0.62%

Dividend Details

Stock Splits

The last stock split was on June 20, 2024. It was a forward split with a ratio of 1.2.

Last Split Date	Jun 20, 2024
Split Type	Forward
Split Ratio	1.2

Scores

Beijing Tiantan Biological Products has an Altman Z-Score of 18.54.

Altman Z-Score	18.54
Piotroski F-Score	n/a